Correlation Between DiaMedica Therapeutics and Senti Biosciences
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Senti Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Senti Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Senti Biosciences, you can compare the effects of market volatilities on DiaMedica Therapeutics and Senti Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Senti Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Senti Biosciences.
Diversification Opportunities for DiaMedica Therapeutics and Senti Biosciences
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between DiaMedica and Senti is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Senti Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Senti Biosciences and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Senti Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Senti Biosciences has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Senti Biosciences go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Senti Biosciences
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to under-perform the Senti Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, DiaMedica Therapeutics is 1.29 times less risky than Senti Biosciences. The stock trades about -0.09 of its potential returns per unit of risk. The Senti Biosciences is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 397.00 in Senti Biosciences on October 21, 2024 and sell it today you would earn a total of 70.00 from holding Senti Biosciences or generate 17.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Senti Biosciences
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Senti Biosciences |
DiaMedica Therapeutics and Senti Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Senti Biosciences
The main advantage of trading using opposite DiaMedica Therapeutics and Senti Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Senti Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senti Biosciences will offset losses from the drop in Senti Biosciences' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |